Implementation and Effectiveness of a Pharmacotherapeutic Follow-Up Service for People with Tuberculosis in Primary Healthcare
- PMID: 36361432
- PMCID: PMC9655657
- DOI: 10.3390/ijerph192114552
Implementation and Effectiveness of a Pharmacotherapeutic Follow-Up Service for People with Tuberculosis in Primary Healthcare
Abstract
Tuberculosis (TB) is a disease of great relevance, responsible for 1.5 million deaths worldwide. Therefore, actions to control TB are necessary, and pharmacists may play an important role, especially in primary healthcare (PHC), where the diagnosis and management of this infection occurs. In a large Brazilian city, pharmacotherapeutic follow-up in PHC has been offered by pharmacists to people with TB since 2018. The objective of this study was to evaluate the implementation and effectiveness of this service though a longitudinal type 1 effectiveness-implementation hybrid study. Data were collected from January 2018 to February 2020 in the pharmaceutical services system. The service indicators were described and effectiveness was evaluated using Poisson regression analysis to compare the incidence of cure among patients using and not using the service. The service was performed in 148 PHC units by 82 pharmacists. Of the total of 1076 treatments, 721 were followed up by pharmacists, and TB was cured more frequently in these cases (90.4% attended vs. 73.5% unattended). The adjusted hazard ratio of cure among patients enrolled in the pharmacotherapeutic follow-up service was 2.71 (2.04-3.61; p < 0.001). Pharmacotherapeutic follow-up for people with TB significantly increased the incidence of cure and should be encouraged.
Keywords: evidence-based pharmacy practice; pharmaceutical services; primary healthcare; tuberculosis.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- World Health Organization (WHO) Global Tuberculosis Report 2021. World Health Organization (WHO); Geneva, Switzerland: 2021. [(accessed on 29 August 2022)]. Available online: https://apps.who.int/iris/handle/10665/346387.
-
- Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis . Guidelines for tuberculosis control in Brazil. Ministério da Saúde; Brasília, Brazil: 2019.
-
- Brasil. Ministério da Saúde Portaria de Consolidação n. 2, de 28 de Setembro de 2017—Consolidação das Normas Sobre as Políticas Nacionais de Saúde do Sistema Único de Saúde. [(accessed on 29 August 2022)]; Available online: https://bvsms.saude.gov.br/bvs/saudelegis/gm/2017/prc0002_03_10_2017.html.
-
- Mkele G. The role of the pharmacist in TB management: Review. SA Pharm. J. 2010;77:18–20. doi: 10.10520/EJC82333. - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
